Intra-Cellular reports mixed fourth-quarter 2024 results, wherein earnings miss estimates but revenues beat the same driven by strong Caplyta sales.

PCRX reports mixed fourth-quarter 2024 results, wherein earnings beat estimates but revenues miss. Exparel sales witness year-over-year growth.

TBPH's fourth-quarter earnings match estimates while sales beat the same marginally. Increased collaboration revenues from Viatris drive revenues...

PEG's fourth-quarter revenues beat the Zacks Consensus Estimate by 6.6%. However, the top line decreases 5.4% from the year-ago level.

OGE's fourth-quarter revenues beat the Zacks Consensus Estimate by 13.1%. The top line also increases 34.2% from the year-ago level.

FSLR's fourth-quarter revenues beat the Zacks Consensus Estimate by 3%. The top line also increases 30.7% from the year-ago level.

EIX's fourth-quarter revenues beat the Zacks Consensus Estimate by 4.9%. The top line also increases 7.5% from the year-ago level.

HAS' fourth-quarter top line reflects dismal contributions from The Wizards of the Coast, and Digital Gaming and Consumer Products segments.

NGVT's top line declines year over year in the fourth quarter due to the repositioning of the Performance Chemicals segment.

TECK Q4 top line reflects gains from record copper production in the quarter.